It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Higher transmissibility of SARS-CoV-2 in cold and dry weather conditions has been hypothesized since the onset of the COVID-19 pandemic but the level of epidemiological evidence remains low. During the first wave of the pandemic, Spain, Italy, France, Portugal, Canada and USA presented an early spread, a heavy COVID-19 burden, and low initial public health response until lockdowns. In a context when testing was limited, we calculated the basic reproduction number (R0) in 63 regions from the growth in regional death counts. After adjusting for population density, early spread of the epidemic, and age structure, temperature and humidity were negatively associated with SARS-CoV-2 transmissibility. A reduction of mean absolute humidity by 1 g/m3 was associated with a 0.15-unit increase of R0. Below 10 °C, a temperature reduction of 1 °C was associated with a 0.16-unit increase of R0. Our results confirm a dependency of SARS-CoV-2 transmissibility to weather conditions in the absence of control measures during the first wave. The transition from summer to winter, corresponding to drop in temperature associated with an overall decrease in absolute humidity, likely contributed to the intensification of the second wave in north-west hemisphere countries. Non-pharmaceutical interventions must be adjusted to account for increased transmissibility in winter conditions.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 IRD, Aix Marseille Univ, INSERM, SESSTIM, Aix Marseille Institute of Public Health, ISSPAM, Marseille, France (GRID:grid.464064.4) (ISNI:0000 0004 0467 0503)
2 Institut Pasteur, UMR2000, CNRS, Mathematical Modelling of Infectious Diseases Unit, Paris, France (GRID:grid.464064.4); Santé publique France, French National Public Health Agency, Saint Maurice, France (GRID:grid.493975.5) (ISNI:0000 0004 5948 8741)
3 IRD, Aix Marseille Univ, INSERM, SESSTIM, Aix Marseille Institute of Public Health, ISSPAM, Marseille, France (GRID:grid.464064.4) (ISNI:0000 0004 0467 0503); Hôpital Européen Marseille, Marseille, France (GRID:grid.492679.7)
4 Institut Pasteur, Emerging Infectious Diseases Unit, Paris, France (GRID:grid.428999.7) (ISNI:0000 0001 2353 6535); Conservatoire National des Arts et Métiers, PACRI Unit, Paris, France (GRID:grid.36823.3c) (ISNI:0000 0001 2185 090X)
5 Institut Pasteur, UMR2000, CNRS, Mathematical Modelling of Infectious Diseases Unit, Paris, France (GRID:grid.36823.3c)
6 Aix Marseille Univ, APHM, INSERM, IRD, SESSTIM, ISSPAM, Hop Timone, BioSTIC, Marseille, France (GRID:grid.5399.6) (ISNI:0000 0001 2176 4817)